Brain Health Assessment for Dementia
(eRADAR Trial)

Recruiting in Palo Alto (17 mi)

+2 other locations

Overseen byDeborah E Barnes, PhD, MPH

Age: 65+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, San Francisco

No Placebo Group

Trial Summary

What is the purpose of this trial?The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Eligibility Criteria

This trial is for individuals who have not been diagnosed with dementia and are not on any dementia medications. Participants must be active patients at a participating clinic and have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot join.

Inclusion Criteria

Active patient at participating clinic

I have never been diagnosed with dementia nor am I on dementia medication.

Adequate data to calculate eRADAR score

Exclusion Criteria

I am currently in hospice care.

Participant Groups

The study is testing a new, cost-effective way to spot dementia early in primary care settings by using something called the Brain Health Assessment, which likely involves tests or questionnaires designed to evaluate memory and thinking skills.

2Treatment groups

Experimental Treatment

Active Control

Group I: Brain Health InterventionExperimental Treatment1 Intervention

Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group II: Usual CareActive Control1 Intervention

Usual care Individuals who meet eligibility criteria will receive usual care.